Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Tumor cells that border normal tissue are told to leave

Tumor cells that border normal tissue are told to leave

January 11, 2006

The thin, single-cell boundary where a tumor meets normal tissue is the most dangerous part of a cancer according to a new study by scientists at Washington University School of Medicine in St. Louis. The researchers found that tumor cells bordering normal tissue receive signals that tell them to wander away from the tumor, allowing the cancer cells to establish deadly metastatic tumors elsewhere in the body.

The researchers say their discovery demonstrates the importance of the tumor's environment and shows more precisely how the metastatic process occurs and might be stopped. Their study appears in the January 10 issue of Developmental Cell.




"What actually kills in cancer is not the primary tumor-it's metastasis," says senior author Ross L. Cagan, Ph.D., associate professor of molecular biology and pharmacology and a researcher with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital. "You can't study that in a laboratory dish. You have to look at the tumor cells in their natural environment-surrounded by normal tissues."

To do this, the research team created tumors in fruit fly eyes and wings that permitted them to study the behavior of individual tumor cells.

"We found that the tumor cells in direct contact with normal cells had a different behavior than cells further inside the tumor," says lead author Marcos Vidal, Ph.D., research associate in molecular biology and pharmacology. "They were exclusively the ones that tended to leave the tissue."

The tumors were generated by turning off an inhibitor of a major oncogene called Src (pronounced sarc), making the tumor cells high in Src oncogene activity. (An oncogene is a gene that increases the malignancy of a tumor cell.) This particular genetic change is common in human breast tumors.

Boundary tumor cells were shown to lose surface proteins that attach them to other cells and stabilize their position within tissues. The study demonstrated that it was the difference in Src activity that led to the change in the attachment proteins. When a high Src cell (tumor cell) was next to a low Src cell (normal cell) the attachment proteins changed their characteristics, and the high Src cell became "unglued."

In addition, this change sent a signal that activated several other proteins in the tumor cell, one of which was an enzyme that dissolves the matrix surrounding cells. This enzyme makes it possible for a cell to move through tissues.

"Even though all the cells in the tumors we created were genetically identical, the proximity of the boundary cells to normal cells-their interaction with normal cells-made them special," Vidal says. "This is the first time the epithelial environment has been shown to play a role in metastasis."

The cells that left the fruit fly tumors eventually succumbed to the natural process of programmed cell death and were eliminated. According to Cagan, that was not unexpected.

"In a tumor, probably 99.99 percent of the border cells are raining out of the edges and dying," Cagan says. "But as oncologists have found, cancer stems from an accumulation of genetic mutations. If one of these wandering cells acquires a second mutation that prevents cell death, it could go on to establish a metastatic tumor."

Having created a model for studying metastasis of tumor cells, the research team has begun to look for ways to manipulate boundary cells to prevent their metastatic behavior. They have seen that disabling some of the genes in the pathway activated in boundary cells stops the cells from leaving the tumor.

Cagan's laboratory also has developed a robotic system for screening anticancer drugs, and they plan to use this system to look for drugs that will affect the metastatic process in their fruit fly model.

"A drug that can prevent metastasis would be an important adjunct for cancer treatments," Cagan says. "It could cut a patient's risk of having tumor cells leave the area before the primary tumor was eradicated. That's essential-metastatic cancer is far harder to treat than early-stage tumors."

Washington University School of Medicine



Related Tumor Cell Current Events and Tumor Cell News Articles Tumor Cell Current Events and Tumor Cell News RSS Tumor Cell Current Events and Tumor Cell News RSS
Researchers identify mechanism used by gene to promote metastasis in human cancer cells
Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers.

A new therapeutic option for human hepatocyte cancer
p53-impaired tumors may be particularly suitable to parvovirus H-1-induced therapy. Although the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the tumor cell susceptibility to H-1 PV-induced oncolytic infections.

New predictive tool can help determine treatment of breast cancer patients
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer - a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery.

New results help predict treatment response in colorectal cancer
Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, late breaking results show.

UAB Anti-Cancer Research Featured in Scientific American
Scientific American magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies.

Nanoparticles + light = dead tumor cells
Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light.

Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.

Novel structure proteins could play a role in apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Counting tumor cells in blood predicts treatment benefit in prostate cancer
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show.

Refusal of suicide order: Why tumor cells become resistant
Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body.
More Tumor Cell Current Events and Tumor Cell News Articles


Cancer Stem Cells: Novel Concepts and Prospects for Tumor Therapy (Ernst Schering Foundation Symposium Proceedings)

Cancer stem cells werehave originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current treatments might largely spare cancer stem cells, thus leading to tumor recurrence and metastasis. The recent identification of growth...



Culture of Human Tumor Cells (Culture of Specialized Cells)

This comprehensive resource provides stepwise protocols for the in vitro cultivation of the major types of human tumors. Written in a reader-friendly style, this book is organized by specific tumor, discussing cultures for lung, gastric, colorectal, pancreas, bladder, prostate, ovary, cervix, mammary carcinoma, myoepithelium, squamous, melanoma, lymphoma, glioma, and neuroendocrine tumors....



Atlas of Human Tumor Cell Lines

Human tumor cells in culture are valuable for studying cancer causes and properties. This convenient reference provides useful information for cancer researchers on commonly used, established tumor cell lines of the major human organ systems.Atlas of Human Tumor Cell Lines includes data about morphological, metabolic, genetic, and growth characteristics of human tumor cells, with morphological...



The Official Patient's Sourcebook on Ovarian Germ Cell Tumors: A Revised and Updated Directory for the Internet Age
by Icon Health Publications

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to ovarian germ cell tumors (also Cancer ovaries; Epithelial ovarian cancer;...

Applied Imaging forms subsidiary to develop advanced technology for detecting circulating tumor cells in blood.: An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on August 1, 2004. The length of the article is 668 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

Immunological xenogenization of tumor cells (Gann monograph on cancer research)

Johannes Muller and the 19th Century Origins of Tumor Cell Theory (Resources in Medical History)
by L. J. Rather, Patricia Rather, J. B. Freriches



Germ Cell Tumors (ACS ATLAS OF CLINICAL ONCOLOGY)
by Derek Raghavan

Crafted as a descriptive and visual text, Germ Cell Tumors features definitive reviews of the biology, diagnosis, and management of germ cell tumors. Incorporating extensive illustrations and tables, this book reviews the progress that has been made in the curative therapy of germ cell tumors over the past 25 years, progress that has lead to the positioning of germ cell tumor therapy as the...

Circulating tumor cells signal outcome in metastatic breast ca.(Gynecology): An article from: OB GYN News
by Bruce Jancin

This digital document is an article from OB GYN News, published by International Medical News Group on April 1, 2005. The length of the article is 524 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Molecular Makers of Brain Tumor Cells
by Bela Bodey, Stuart E. Siegel, Hans E. Kaiser

I. MOLECULAR BIOLOGY OF TUMORS. 1. Brain Tumors 2. Immunophenotypic Characterization of Infiltrating Poly- and Mononuclear Cells in Childhood Brain Tumors II. ANTI-NEOPLASTIC BIOLOGICAL THERAPIES 3. Experimental Therapies in Brain Tumors 4. Biologic Anti-Neoplastic Therapies 5. The lymphokine activated killer (LAK) cell phenomenon 6. Angiogenesis Inhibition in...

© 2008 BrightSurf.com